Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

PRKAR1A Produkte

(Protein Kinase, CAMP-Dependent, Regulatory, Type I, alpha (Tissue Specific Extinguisher 1) (PRKAR1A))

Kategorien

cAMP is a signaling molecule important for a variety of cellular functions. cAMP exerts its effects by activating the cAMP-dependent protein kinase, which transduces the signal through phosphorylation of different target proteins. The inactive kinase holoenzyme is a tetramer composed of two regulatory and two catalytic subunits. cAMP causes the dissociation of the inactive holoenzyme into a dimer of regulatory subunits bound to four cAMP and two free monomeric catalytic subunits. Four different regulatory subunits and three catalytic subunits have been identified in humans. This gene encodes one of the regulatory subunits. This protein was found to be a tissue-specific extinguisher that down-regulates the expression of seven liver genes in hepatoma x fibroblast hybrids. Mutations in this gene cause Carney complex (CNC). This gene can fuse to the RET protooncogene by gene rearrangement and form the thyroid tumor-specific chimeric oncogene known as PTC2. A nonconventional nuclear localization sequence (NLS) has been found for this protein which suggests a role in DNA replication via the protein serving as a nuclear transport protein for the second subunit of the Replication Factor C (RFC40). Several alternatively spliced transcript variants encoding two different isoforms have been observed. [provided by RefSeq, Jan 2013].

antibodies-online.com steht für hochwertige Forschungsprodukte. Suchen, finden und bestellen Sie Tools mit umfangreichen Validierungsdaten, Bildern, Referenzen. Unser wissenschaftlicher Kundenservice steht Ihnen jederzeit zur Verfügung, wenn Sie Fragen zur Auswahl oder Anwendung unserer Produkte haben.

Ausgewählte PRKAR1A Kategorien

PRKAR1A Antikörper

High quality antibodies with extensive validation data.

PRKAR1A Proteine

Proteins for various applications incl. WB, ELISA, IF etc.

Empfohlene PRKAR1A Antikörper

Produkt
Reaktivität
Applikation
Validierungen
Kat. Nr.
Menge
Datenblatt
Reaktivität Human
Applikation WB, IF
Validierungen
  • (5)
Kat. Nr. ABIN3021148
Menge 100 μL
Datenblatt Datenblatt
Reaktivität Human, Mouse, Rat
Applikation WB, ELISA, IHC, IF, ICC
Validierungen
  • (3)
Kat. Nr. ABIN6264423
Menge 100 μL
Datenblatt Datenblatt
Reaktivität Human, Rat
Applikation WB, IHC (p)
Validierungen
  • (4)
Kat. Nr. ABIN5518788
Menge 100 μg
Datenblatt Datenblatt

Empfohlene PRKAR1A ELISA Kits

Produkt
Reaktivität
Analytical Method
Validierungen
Kat. Nr.
Menge
Datenblatt
Reaktivität Human, Mouse, Rat
Analytical Method Qualitative Cell ELISA
Validierungen
Kat. Nr. ABIN5648035
Menge 96 tests
Datenblatt Datenblatt
Reaktivität Human
Analytical Method Quantitative Sandwich ELISA
Validierungen
Kat. Nr. ABIN6730540
Menge 96 tests
Datenblatt Datenblatt

Empfohlene PRKAR1A Proteine

Produkt
Reaktivität
Source
Validierungen
Kat. Nr.
Menge
Datenblatt
Reaktivität Human
Source Wheat germ
Validierungen
  • (1)
Kat. Nr. ABIN1316241
Menge 10 μg
Datenblatt Datenblatt
Reaktivität Human
Source Wheat germ
Validierungen
  • (1)
Kat. Nr. ABIN1316243
Menge 10 μg
Datenblatt Datenblatt
Reaktivität Human
Source Human Cells
Validierungen
Kat. Nr. ABIN7318228
Menge 50 μg
Datenblatt Datenblatt

Neueste Publikationen zu unseren PRKAR1A Produkten

Graham, Lackner, Terracciano, González-Cantú, Maleszewski, Greipp, Simon, Torbenson: "Fibrolamellar carcinoma in the Carney complex: PRKAR1A loss instead of the classic DNAJB1-PRKACA fusion." in: Hepatology (Baltimore, Md.), Vol. 68, Issue 4, pp. 1441-1447, (2019) (PubMed).

Graham, Terracciano, Meves, Vanderboom, Dasari, Yeh, Torbenson, Cruise: "Hepatic adenomas with synchronous or metachronous fibrolamellar carcinomas: both are characterized by LFABP loss." in: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, Vol. 29, Issue 6, pp. 607-15, (2018) (PubMed).

Cao, Xia, Zhou, Yang, Hao, Peng, Liu, Zhu: "Methylcrotonoyl-CoA carboxylase 1 potentiates RLR-induced NF-κB signaling by targeting MAVS complex." in: Scientific reports, Vol. 6, pp. 33557, (2016) (PubMed).

Sousa, Gomez, Diniz, Bernardes, Soares, Brito, Liu, Pontes, Stratakis, Gomes: "Defects of the Carney complex gene (PRKAR1A) in odontogenic tumors." in: Endocrine-related cancer, Vol. 22, Issue 3, pp. 399-408, (2015) (PubMed).

Maleszewski, Larsen, Kip, Castonguay, Edwards, Carney, Kipp: "PRKAR1A in the development of cardiac myxoma: a study of 110 cases including isolated and syndromic tumors." in: The American journal of surgical pathology, Vol. 38, Issue 8, pp. 1079-87, (2014) (PubMed).

Wells, OReilly, Szul, Sullivan, Handley, Garrett, McNicholas, Roda, Miller, Tal-Singer, Gaggar, Rennard, Jackson, Blalock: "An aberrant leukotriene A4 hydrolase-proline-glycine-proline pathway in the pathogenesis of chronic obstructive pulmonary disease." in: American journal of respiratory and critical care medicine, Vol. 190, Issue 1, pp. 51-61, (2014) (PubMed).

Shajahan-Haq, Cook, Schwartz-Roberts, Eltayeb, Demas, Warri, Facey, Hilakivi-Clarke, Clarke: "MYC regulates the unfolded protein response and glucose and glutamine uptake in endocrine resistant breast cancer." in: Molecular cancer, Vol. 13, pp. 239, (2014) (PubMed).

Zhao, Li, Wohlford-Lenane, Agnihothram, Fett, Zhao, Gale, Baric, Enjuanes, Gallagher, McCray, Perlman: "Rapid generation of a mouse model for Middle East respiratory syndrome." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 111, Issue 13, pp. 4970-5, (2014) (PubMed).

Tian, Jiang, Tamosiuniene, Sung, Qian, Dhillon, Gera, Farkas, Rabinovitch, Zamanian, Inayathullah, Fridlib, Rajadas, Peters-Golden, Voelkel, Nicolls: "Blocking macrophage leukotriene b4 prevents endothelial injury and reverses pulmonary hypertension." in: Science translational medicine, Vol. 5, Issue 200, pp. 200ra117, (2013) (PubMed).

Wang, Henry, Distefano, Wang, Räikkönen, Mönkkönen, Tanaka, Morita: "Butyrophilin 3A1 plays an essential role in prenyl pyrophosphate stimulation of human V?2V?2 T cells." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 191, Issue 3, pp. 1029-42, (2013) (PubMed).

Synonyme und alternative Namen zu PRKAR1A

protein kinase cAMP-dependent type I regulatory subunit alpha (PRKAR1A), protein kinase, cAMP dependent regulatory, type I, alpha (Prkar1a), protein kinase cAMP-dependent type 1 regulatory subunit alpha (Prkar1a), protein kinase, cAMP-dependent, regulatory, type I, alpha (tissue specific extinguisher 1) a (prkar1aa), cAMP-dependent protein kinase type I-alpha regulatory subunit pseudogene (LOC707275), protein kinase cAMP-dependent type I regulatory subunit alpha (Prkar1a), protein kinase cAMP-dependent type I regulatory subunit alpha S homeolog (prkar1a.S), 1300018C22Rik, ACRDYS1, ADOHR, CAR, CNC, CNC1, cnc1, im:7047729, PKR1, pkr1, PPNAD1, ppnad1, PRKAR1, prkar1, prkar1a, RIalpha, RIIA, Tse-1, TSE1, Tse1, tse1, zgc:92515

Bezeichner auf Proteinebene für PRKAR1A

  • cAMP-dependent protein kinase regulatory subunit RIalpha
  • cAMP-dependent protein kinase type I-alpha regulatory chain
  • cAMP-dependent protein kinase type I-alpha regulatory subunit
  • protein kinase A type 1a regulatory subunit
  • tissue-specific extinguisher 1
  • protein kinase, cAMP dependent regulatory, type 1, alpha
  • protein kinase, cAMP dependent regulatory, type I, alpha
  • cAMP-dependent protein kinase type I regulatory subunit
  • protein kinase, cAMP-dependent, regulatory, type I, alpha (tissue specific extinguisher 1)
  • cAMP-dependent protein kinase, regulatory subunit alpha 1
  • cAMP-dependent protein kinase regulatory subunit alpha 1
  • cAMP-dependent protein kinase type I-alpha regulatory subunit-like
  • protein kinase, cAMP-dependent, regulatory subunit type I alpha S homeolog
Sie sind hier:
Kundenservice